Quidel Corporation QDEL was a big mover last session, as the company saw its shares jump above 25% on the day. The upside was driven by company’s announcement to acquire the Triage MeterPro cardiovascular and toxicology assets, and the B-type Naturietic Peptide assay business run on Beckman Coulter analyzers from Alere Inc. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 34% in the past one-month time frame.

The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Quidel Corporation currently holds a Zacks Rank #2 (Buy).

Quidel Corporation Price

Quidel Corporation Price | Quidel Corporation Quote

Another top-ranked stock in the Medical - Products industry is OraSure Technologies, Inc. OSUR, which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is QDEL going up? Or down? Predict to see what others think: Up or Down

5 Trades Could Profit ""Big-League"" from Trump Policies                                                                                                            

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
OraSure Technologies, Inc. (OSUR) : Free Stock Analysis Report
 
Quidel Corporation (QDEL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research